Clinical Trial Update: Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan [Phase 3]

View source ↗

Summary

Phase 3 trial comparing celecoxib, loxoprofen, and placebo for low back pain in Japan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Celecoxib 200 mg bid (celecoxib)
• Loxoprofen Sodium 60 mg tid (loxoprofen)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED